Skip to main content

Scientists Discover Way to Send Information into Black Holes Without Using Energy

Post a Comment

Stanford’s Tiny Eye Chip Helps the Blind See Again

Imagine being able to read a book, recognize a loved one’s face, or see a street sign again — after years of blindness. For many people suffering from severe vision loss, that dream has long seemed impossible. But now, a breakthrough from Stanford Medicine is turning it into reality.

A tiny wireless eye chip, no bigger than a grain of rice, has given people with advanced macular degeneration the ability to see again. Combined with a special pair of smart glasses, this implant — known as the PRIMA system — is helping the blind regain functional vision, read books, and navigate the world once more.

In a clinical study published on October 20 in the New England Journal of Medicine, 27 out of 32 participants who received the implant regained the ability to read within a year. Some even reached vision levels comparable to 20/42, meaning they could see with clarity close to that of normal sight.

The results mark one of the most significant milestones in modern ophthalmology — and a major leap toward curing blindness caused by retinal degeneration.

The Birth of the PRIMA Vision System

The PRIMA project was led by Daniel Palanker, PhD, professor of ophthalmology at Stanford Medicine, along with José-Alain Sahel, MD, of the University of Pittsburgh School of Medicine, and Frank Holz, MD, of the University of Bonn in Germany.

Their mission: to create an artificial retina that could replace the function of lost photoreceptor cells — the light-sensitive cells in our eyes that enable us to see.

According to Dr. Palanker, “All previous attempts to restore vision using prosthetic devices could only bring back light perception — flashes or vague shadows. We are the first to provide form vision — the ability to recognize shapes, patterns, and eventually read.”

That’s what makes the PRIMA system so revolutionary. It doesn’t just let patients detect light; it allows them to actually see.

How the Eye Chip Works

The PRIMA system is made up of two main components:

  1. A microchip implant placed at the back of the eye (in the retina)

  2. A pair of smart glasses that capture and transmit visual information

Here’s how it works:

  • The glasses are equipped with a miniature camera that captures the surrounding scene.

  • This visual information is converted into infrared light signals and projected into the eye.

  • The chip — which is sensitive to infrared light — receives this signal and turns it into tiny electrical pulses.

  • These pulses stimulate the remaining healthy retinal neurons, which then send visual data to the brain through the optic nerve.

In essence, the PRIMA system bypasses damaged photoreceptors and takes over their role. The brain interprets these electrical signals as visual images — restoring the ability to see.

Dr. Palanker explains, “The eye is transparent. So instead of inserting wires or external power sources, we use light itself to transmit information. The device is fully wireless and powered by light — it’s photovoltaic.”

This design not only makes the implant safer but also ensures that patients can use it comfortably without bulky cables or external batteries.

Combining Natural and Artificial Vision

One of PRIMA’s most unique features is that it allows patients to combine their natural peripheral vision with artificial central vision from the implant.

In advanced macular degeneration, central vision — used for reading and recognizing faces — is lost, but peripheral vision often remains. The PRIMA chip fills in that missing center, allowing the two types of vision to merge.

“The fact that they see both prosthetic and peripheral vision simultaneously is very important,” said Palanker. “It allows users to orient themselves naturally and move around safely.”

Because the implant detects infrared light, it doesn’t interfere with remaining photoreceptors in the eye. This means patients can use their natural sight and the artificial vision from the chip together, giving them a fuller picture of their surroundings.

What Is Macular Degeneration?

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness among older adults. It affects over 5 million people worldwide.

In AMD, the central part of the retina — called the macula — gradually deteriorates. The macula is responsible for sharp, detailed vision, which we need for tasks like reading or recognizing faces. As the photoreceptor cells die off, patients are left with a dark or blurry spot in the center of their vision.

In the most severe form, known as geographic atrophy, this central vision loss becomes complete and permanent.

Until now, there has been no effective treatment for restoring vision once photoreceptors are gone. PRIMA changes that.

By using surviving retinal neurons and stimulating them electrically, the implant provides a new way for the brain to receive visual information — even in eyes that have lost their natural light sensors.

A Journey 20 Years in the Making

Dr. Palanker first imagined the concept behind PRIMA nearly two decades ago.

“I was working with ophthalmic lasers and realized that since the eye is transparent, we could send information directly to the retina using light,” he recalls.

What began as an idea in 2005 has now become a functioning technology that restores vision in real patients.

The journey to this breakthrough involved years of prototypes, animal studies, and early-stage human trials — all leading to this major clinical success.

“The device we imagined 20 years ago now works remarkably well in patients,” said Palanker. “It’s incredibly rewarding to see that vision restored.”

The Clinical Trial: Restoring Sight to the Blind

The latest PRIMA trial involved 38 patients aged 60 or older who suffered from advanced macular degeneration and had vision worse than 20/320 in at least one eye — legally blind by medical standards.

Each patient received the implant in one eye. After about a month of recovery, they began using the PRIMA smart glasses.

While some could immediately recognize patterns, most required training sessions over several months to interpret the new type of visual input.

“It’s similar to how people with cochlear implants must train their brains to understand artificial hearing,” Palanker explained.

After one year, the results were extraordinary:

  • 27 out of 32 participants regained the ability to read printed text.

  • 26 showed clinically meaningful improvement in visual acuity — defined as reading at least two additional lines on an eye chart.

  • On average, patients’ vision improved by five lines.

  • One participant improved by twelve lines — an almost miraculous recovery.

Using digital features on the glasses — such as adjustable zoom, contrast enhancement, and brightness control — some participants achieved visual sharpness close to 20/42.

With this new vision, they could read books, food labels, and subway signs — things that were once impossible.

Two-thirds of the participants reported medium to high satisfaction with the device, calling it “life-changing.”

Side Effects and Safety

As with any medical implant, some patients experienced side effects.

In total, 19 participants reported issues such as:

  • Ocular hypertension (increased eye pressure)

  • Peripheral retinal tears

  • Subretinal hemorrhage (small amounts of bleeding beneath the retina)

However, these complications were non-life-threatening and typically resolved within two months.

The study concluded that the PRIMA implant is safe, stable, and effective for restoring functional vision in people with advanced macular degeneration.

Life After the Implant

For many participants, the return of vision meant far more than just reading letters on a chart. It meant regaining independence, confidence, and joy.

One participant described being able to read the labels on grocery items again. Another could recognize signs in the subway for the first time in years.

Although the current version only provides black-and-white vision, it has already transformed lives.

Dr. Palanker and his team are now working on software updates that will allow grayscale perception, which is essential for face recognition — one of the most requested features by patients.

“Number one on the patients’ wish list is reading,” he said. “But number two, very close behind, is recognizing faces. And that requires grayscale.”

Next Steps: Toward Near-Normal Vision

While the first version of the PRIMA chip already represents a medical miracle, researchers believe this is just the beginning.

The current chip has 378 pixels, each 100 microns wide. The next-generation model — already being tested in animals — will have 10,000 pixels just 20 microns wide.

This higher pixel density could dramatically improve image resolution, potentially giving patients 20/80 vision or better.

“With electronic zoom, they could even approach 20/20 — nearly normal vision,” Palanker said.

Future versions will also feature sleeker, more stylish glasses and improved processing speed for real-time visual feedback.

Beyond macular degeneration, the PRIMA system could eventually help people with other conditions that cause photoreceptor loss, such as retinitis pigmentosa or inherited retinal dystrophies.

Why This Matters

Restoring sight has long been considered one of medicine’s greatest challenges. The human eye is incredibly complex, and once the delicate photoreceptors are destroyed, they cannot regenerate naturally.

The PRIMA chip overcomes that limitation by creating a digital interface between the eye and the brain.

It represents a new frontier in bioengineering — a perfect blend of neuroscience, optics, and electronics.

For patients, it’s not just about science — it’s about getting their lives back. Being able to see a grandchild’s smile, navigate a city street, or enjoy the beauty of a sunset again is nothing short of a miracle.

Global Collaboration and Future Trials

The success of the PRIMA system was made possible through a global collaboration of researchers and medical centers across the United States and Europe.

The trial involved experts from Stanford Medicine, the University of Pittsburgh, the University of Bonn, and over a dozen other hospitals worldwide.

Their findings — published under the title “Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD” in the New England Journal of Medicine — are being hailed as a landmark in ophthalmic research.

The next step will involve larger international trials, long-term follow-ups, and eventual approval for widespread clinical use.

If all goes well, the PRIMA device could become commercially available within the next few years, offering hope to millions suffering from untreatable blindness.

A Glimpse Into the Future

As technology continues to evolve, the boundary between biology and electronics is rapidly blurring. Devices like PRIMA are part of a new generation of bionic implants designed to restore or even enhance human senses.

Just as cochlear implants revolutionized hearing restoration, the PRIMA eye implant could transform how we treat blindness.

With continued innovation, future versions might even surpass natural human vision, offering capabilities like adjustable zoom, night vision, and digital overlays — merging sight and technology in ways once confined to science fiction.

Conclusion: A Visionary Breakthrough

The Stanford-developed PRIMA chip is far more than a medical device — it’s a symbol of hope.

For decades, scientists have dreamed of restoring vision to the blind. Now, that dream is finally becoming real.

Through light-powered technology, advanced microengineering, and relentless research, the PRIMA system proves that blindness caused by retinal degeneration doesn’t have to be permanent.

As Dr. Palanker summarized, “This is just the first step. The next generation of implants will bring us even closer to restoring natural, high-resolution vision.”

A future where blindness can be reversed is no longer a fantasy — it’s on the horizon, thanks to a tiny chip born at Stanford and the extraordinary vision of the people behind it.

Journal Reference:

  1. Frank G. Holz, Yannick Le Mer, Mahiul M.K. Muqit, Lars-Olof Hattenbach, Andrea Cusumano, Salvatore Grisanti, Laurent Kodjikian, Marco Andrea Pileri, Frederic Matonti, Eric Souied, Boris V. Stanzel, Peter Szurman, Michel Weber, Karl Ulrich Bartz-Schmidt, Nicole Eter, Marie Noelle Delyfer, Jean François Girmens, Koen A. van Overdam, Armin Wolf, Ralf Hornig, Martina Corazzol, Frank Brodie, Lisa Olmos de Koo, Daniel Palanker, José-Alain Sahel. Subretinal Photovoltaic Implant to Restore Vision in Geographic Atrophy Due to AMD. New England Journal of Medicine, 2025; DOI: 10.1056/NEJMoa2501396

Comments

Post a Comment

Popular

Scientists Discover Way to Send Information into Black Holes Without Using Energy

For years, scientists believed that adding even one qubit (a unit of quantum information) to a black hole needed energy. This was based on the idea that a black hole’s entropy must increase with more information, which means it must gain energy. But a new study by Jonah Kudler-Flam and Geoff Penington changes that thinking. They found that quantum information can be teleported into a black hole without adding energy or increasing entropy . This works through a process called black hole decoherence , where “soft” radiation — very low-energy signals — carry information into the black hole. In their method, the qubit enters the black hole while a new pair of entangled particles (like Hawking radiation) is created. This keeps the total information balanced, so there's no violation of the laws of physics. The energy cost only shows up when information is erased from the outside — these are called zerobits . According to Landauer’s principle, erasing information always needs energy. But ...
Post a Comment
Read more

Black Holes That Never Dies

Black holes are powerful objects in space with gravity so strong that nothing can escape them. In the 1970s, Stephen Hawking showed that black holes can slowly lose energy by giving off tiny particles. This process is called Hawking radiation . Over time, the black hole gets smaller and hotter, and in the end, it disappears completely. But new research by Menezes and his team shows something different. Using a theory called Loop Quantum Gravity (LQG) , they studied black holes with quantum corrections. In their model, the black hole does not vanish completely. Instead, it stops shrinking when it reaches a very small size. This leftover is called a black hole remnant . They also studied something called grey-body factors , which affect how much energy escapes from a black hole. Their findings show that the black hole cools down and stops losing mass once it reaches a minimum mass . This new model removes the idea of a “singularity” at the center of the black hole and gives us a better ...
Post a Comment
Read more

How Planetary Movements Might Explain Sunspot Cycles and Solar Phenomena

Sunspots, dark patches on the Sun's surface, follow a cycle of increasing and decreasing activity every 11 years. For years, scientists have relied on the dynamo model to explain this cycle. According to this model, the Sun's magnetic field is generated by the movement of plasma and the Sun's rotation. However, this model does not fully explain why the sunspot cycle is sometimes unpredictable. Lauri Jetsu, a researcher, has proposed a new approach. Jetsu’s analysis, using a method called the Discrete Chi-square Method (DCM), suggests that planetary movements, especially those of Earth, Jupiter, and Mercury, play a key role in driving the sunspot cycle. His theory focuses on Flux Transfer Events (FTEs), where the magnetic fields of these planets interact with the Sun’s magnetic field. These interactions could create the sunspots and explain other solar phenomena like the Sun’s magnetic polarity reversing every 11 years. The Sun, our closest star, has been a subject of scient...
Post a Comment
Read more